Verve Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Bcomp manufactures powerRibs™, a natural fibre reinforcement grid for composite structures that mimics leaf-vein patterns to provide high stiffness at minimal weight.
Advanced ManufacturingCircular EconomyCleantechNew MaterialsFribourg, CH
Co-investorsBMW i VenturesAirbus VenturesPorsche VenturesRKKVCVolvo Cars Tech Fund
Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.
BiotechMedical DevicesZurich, CH
Co-investorsKurma PartnersPureos BioventuresYsios CapitalAdjuvant CapitalFresenius Medical Care Venturesredalpine
Somagenetix is a gene therapy company that develops treatments for genetic diseases, particularly phagocyte-driven immune and neurodegenerative disorders, by correcting DNA at its source.
BiotechDeep TechHealthtechMedical DevicesZurich, CH
Co-investorsVI Partners
Transmutex develops accelerator-powered technology that converts nuclear waste into clean energy and produces medical radioisotopes.
Deep TechEnergyMedical Devices
Franklin Servan-Schreiber(Founder & CEO)
Co-investors4see VenturesAlleyCorpAt One VenturesHCVCSteel AtlasUnion Square Ventures (USV)+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.